UPDATE: Wunderlich Initiates Coverage on DexCom at Buy

According to Wunderlich Securities, DexCom

coverage is initiated at Buy. Wunderlich Securities said that it is initiating coverage of DexCom, Inc. (

) with a Buy rating and $12 target. “We believe growing visibility on the Gen4 approval process will allow DXCM shares to reach, and possibly exceed, our $12 price target over the next 12 months.” DexCom closed yesterday at $8.54.